Literature DB >> 20590562

Phytocannabinoids beyond the Cannabis plant - do they exist?

Jürg Gertsch1, Roger G Pertwee, Vincenzo Di Marzo.   

Abstract

It is intriguing that during human cultural evolution man has detected plant natural products that appear to target key protein receptors of important physiological systems rather selectively. Plants containing such secondary metabolites usually belong to unique chemotaxa, induce potent pharmacological effects and have typically been used for recreational and medicinal purposes or as poisons. Cannabis sativa L. has a long history as a medicinal plant and was fundamental in the discovery of the endocannabinoid system. The major psychoactive Cannabis constituent Delta(9)-tetrahydrocannabinol (Delta(9)-THC) potently activates the G-protein-coupled cannabinoid receptor CB(1) and also modulates the cannabinoid receptor CB(2). In the last few years, several other non-cannabinoid plant constituents have been reported to bind to and functionally interact with CB receptors. Moreover, certain plant natural products, from both Cannabis and other plants, also target other proteins of the endocannabinoid system, such as hydrolytic enzymes that control endocannabinoid levels. In this commentary we summarize and critically discuss recent findings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590562      PMCID: PMC2931553          DOI: 10.1111/j.1476-5381.2010.00745.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  Discovery of potent and reversible monoacylglycerol lipase inhibitors.

Authors:  Alvin R King; Emmanuel Y Dotsey; Alessio Lodola; Kwang Mook Jung; Azar Ghomian; Yan Qiu; Jin Fu; Marco Mor; Daniele Piomelli
Journal:  Chem Biol       Date:  2009-10-30

2.  Trick or treat from food endocannabinoids?

Authors:  V Di Marzo; N Sepe; L De Petrocellis; A Berger; G Crozier; E Fride; R Mechoulam
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

Review 3.  Polyphenols: biological activities, molecular targets, and the effect of methylation.

Authors:  K R Landis-Piwowar; Q P Dou
Journal:  Curr Mol Pharmacol       Date:  2008-11       Impact factor: 3.339

4.  Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin.

Authors:  Marco Leonti; Laura Casu; Stefan Raduner; Filippo Cottiglia; Costantino Floris; Karl-Heinz Altmann; Jürg Gertsch
Journal:  Biochem Pharmacol       Date:  2010-03-03       Impact factor: 5.858

5.  The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.

Authors:  L Thors; K Alajakku; C J Fowler
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

6.  In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens.

Authors:  Judith M Rollinger; Daniela Schuster; Birgit Danzl; Stefan Schwaiger; Patrick Markt; Michaela Schmidtke; Jürg Gertsch; Stefan Raduner; Gerhard Wolber; Thierry Langer; Hermann Stuppner
Journal:  Planta Med       Date:  2008-12-18       Impact factor: 3.352

7.  Tea catechins' affinity for human cannabinoid receptors.

Authors:  G Korte; A Dreiseitel; P Schreier; A Oehme; S Locher; S Geiger; J Heilmann; P G Sand
Journal:  Phytomedicine       Date:  2009-11-07       Impact factor: 5.340

Review 8.  Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?

Authors:  Susanne Oesch; Jürg Gertsch
Journal:  J Pharm Pharmacol       Date:  2009-07       Impact factor: 3.765

9.  An examination of anthocyanins' and anthocyanidins' affinity for cannabinoid receptors.

Authors:  Gabriele Korte; Andrea Dreiseitel; Peter Schreier; Anett Oehme; Sanja Locher; Goeran Hajak; Philipp G Sand
Journal:  J Med Food       Date:  2009-12       Impact factor: 2.786

10.  Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans.

Authors:  Karin Woelkart; Peter Dittrich; Eckhard Beubler; Fritz Pinl; Roland Schoop; Andy Suter; Rudolf Bauer
Journal:  Planta Med       Date:  2008-01-31       Impact factor: 3.352

View more
  43 in total

1.  Themed issue: cannabinoids.

Authors:  S P H Alexander; K Mackie; R A Ross
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.

Authors:  Angelo A Izzo; Raffaele Capasso; Gabriella Aviello; Francesca Borrelli; Barbara Romano; Fabiana Piscitelli; Laura Gallo; Francesco Capasso; Pierangelo Orlando; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Chromenopyrazoles: non-psychoactive and selective CB₁ cannabinoid agonists with peripheral antinociceptive properties.

Authors:  Jose Cumella; Laura Hernández-Folgado; Rocio Girón; Eva Sánchez; Paula Morales; Dow P Hurst; Maria Gómez-Cañas; Maria Gómez-Ruiz; Diana C G A Pinto; Pilar Goya; Patricia H Reggio; María Isabel Martin; Javier Fernández-Ruiz; Artur M S Silva; Nadine Jagerovic
Journal:  ChemMedChem       Date:  2012-02-02       Impact factor: 3.466

4.  The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors.

Authors:  A Chicca; J Marazzi; J Gertsch
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

5.  Gene Networks Underlying Cannabinoid and Terpenoid Accumulation in Cannabis.

Authors:  Jordan J Zager; Iris Lange; Narayanan Srividya; Anthony Smith; B Markus Lange
Journal:  Plant Physiol       Date:  2019-05-28       Impact factor: 8.340

6.  Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.

Authors:  Luciano De Petrocellis; Alessia Ligresti; Aniello Schiano Moriello; Mariagrazia Iappelli; Roberta Verde; Colin G Stott; Luigia Cristino; Pierangelo Orlando; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

7.  Characterization of the intrinsic activity for a novel class of cannabinoid receptor ligands: Indole quinuclidine analogs.

Authors:  Lirit N Franks; Benjamin M Ford; Nikhil R Madadi; Narsimha R Penthala; Peter A Crooks; Paul L Prather
Journal:  Eur J Pharmacol       Date:  2014-05-20       Impact factor: 4.432

8.  Cannabidiol inhibits angiogenesis by multiple mechanisms.

Authors:  M Solinas; P Massi; A R Cantelmo; M G Cattaneo; R Cammarota; D Bartolini; V Cinquina; M Valenti; L M Vicentini; D M Noonan; A Albini; D Parolaro
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 9.  Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?

Authors:  Jürg Gertsch
Journal:  Br J Pharmacol       Date:  2017-01-16       Impact factor: 8.739

Review 10.  The Role of the Endocannabinoid System in the Brain-Gut Axis.

Authors:  Keith A Sharkey; John W Wiley
Journal:  Gastroenterology       Date:  2016-04-29       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.